MacroGenics (NASDAQ:MGNX – Get Free Report) is projected to post its quarterly earnings results after the market closes on Thursday, March 20th. Analysts expect MacroGenics to post earnings of ($0.23) per share and revenue of $34.17 million for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.
MacroGenics Stock Down 1.8 %
Shares of NASDAQ MGNX opened at $2.18 on Tuesday. The firm’s 50-day moving average price is $2.75 and its two-hundred day moving average price is $3.26. MacroGenics has a 52-week low of $2.14 and a 52-week high of $19.54. The stock has a market capitalization of $136.82 million, a P/E ratio of -1.38 and a beta of 2.12.
MacroGenics Company Profile
See Also
- Five stocks we like better than MacroGenics
- Most active stocks: Dollar volume vs share volume
- Can TikTok Stock Picks Really Make You Rich?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- The “Quality” Rotation: Back to Basics Investing
- 3 Tickers Leading a Meme Stock Revival
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for MacroGenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MacroGenics and related companies with MarketBeat.com's FREE daily email newsletter.